• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生长分化因子 15:在肝脏疾病中的新作用。

Growth differentiation factor 15: Emerging role in liver diseases.

机构信息

Department of Gastroenterology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

Department of Rheumatology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China.

出版信息

Cytokine. 2024 Oct;182:156727. doi: 10.1016/j.cyto.2024.156727. Epub 2024 Aug 6.

DOI:10.1016/j.cyto.2024.156727
PMID:39111112
Abstract

Growth differentiation factor 15 (GDF15) is a cell stress-response cytokine within the transforming growth factor-β (TGFβ) superfamily. It is known to exert diverse effects on many metabolic pathways through its receptor GFRAL, which is expressed in the hindbrain, and transduces signals through the downstream receptor tyrosine kinase Ret. Since the liver is the core organ of metabolism, summarizing the functions of GDF15 is highly important. In this review, we assessed the relevant literature regarding the main metabolic, inflammatory, fibrogenic, tumorigenic and other effects of GDF15 on different liver diseases, including Metabolic dysfunction-associated steatotic liver disease(MASLD), alcohol and drug-induced liver injury, as well as autoimmune and viral hepatitis, with a particular focus on the pathogenesis of MASLD progression from hepatic steatosis to MASH, liver fibrosis and even hepatocellular carcinoma (HCC). Finally, we discuss the prospects of the clinical application potential of GDF15 along with its research and development progress. With better knowledge of GDF15, increasing in-depth research will lead to a new era in the field of liver diseases.

摘要

生长分化因子 15(GDF15)是转化生长因子-β(TGFβ)超家族中的一种细胞应激反应细胞因子。它通过其在后脑表达的受体 GFRAL 对许多代谢途径发挥多种作用,并通过下游受体酪氨酸激酶 Ret 转导信号。由于肝脏是代谢的核心器官,因此总结 GDF15 的功能非常重要。在这篇综述中,我们评估了关于 GDF15 对不同肝病的主要代谢、炎症、纤维化、致瘤和其他作用的相关文献,包括代谢功能障碍相关脂肪性肝病(MASLD)、酒精和药物性肝损伤以及自身免疫性和病毒性肝炎,特别关注了 MASLD 从肝脂肪变性进展为 MASH、肝纤维化甚至肝细胞癌(HCC)的发病机制。最后,我们讨论了 GDF15 的临床应用潜力及其研究和开发进展。随着对 GDF15 的认识不断提高,深入研究将引领肝病领域的新时代。

相似文献

1
Growth differentiation factor 15: Emerging role in liver diseases.生长分化因子 15:在肝脏疾病中的新作用。
Cytokine. 2024 Oct;182:156727. doi: 10.1016/j.cyto.2024.156727. Epub 2024 Aug 6.
2
RASSF4 Attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease Progression via Hippo Signaling and Suppresses Hepatocarcinogenesis.RASSF4 通过 Hippo 信号通路减轻代谢相关脂肪性肝病的进展并抑制肝癌发生。
Cell Mol Gastroenterol Hepatol. 2024;18(2):101348. doi: 10.1016/j.jcmgh.2024.04.005. Epub 2024 Apr 30.
3
miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression.肝细胞中 miR-33 的缺失可减轻 MASLD-MASH-HCC 的进展。
JCI Insight. 2024 Aug 27;9(19):e168476. doi: 10.1172/jci.insight.168476.
4
Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.肝细胞癌中的肝星状细胞通过生长分化因子 15 的产生促进肿瘤生长。
Gastroenterology. 2021 Apr;160(5):1741-1754.e16. doi: 10.1053/j.gastro.2020.12.015. Epub 2020 Dec 17.
5
Glucagon augments the secretion of FGF21 and GDF15 in MASLD by indirect mechanisms.胰高血糖素通过间接机制增强 MASLD 中 FGF21 和 GDF15 的分泌。
Metabolism. 2024 Jul;156:155915. doi: 10.1016/j.metabol.2024.155915. Epub 2024 Apr 16.
6
Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with MASLD regardless of liver fibrosis.血清生长分化因子 15 是一种新型生物标志物,具有很高的预测能力,可用于预测 MASLD 患者发生肝癌,无论是否存在肝纤维化。
Aliment Pharmacol Ther. 2024 Aug;60(3):327-339. doi: 10.1111/apt.18063. Epub 2024 Jun 3.
7
A male mouse model for metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma.一种用于代谢功能障碍相关脂肪性肝病和肝细胞癌的雄性小鼠模型。
Nat Commun. 2024 Aug 2;15(1):6506. doi: 10.1038/s41467-024-50660-y.
8
Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice.生长分化因子 15 可改善小鼠的非酒精性脂肪性肝炎及相关代谢紊乱。
Sci Rep. 2018 May 1;8(1):6789. doi: 10.1038/s41598-018-25098-0.
9
Roles of immune dysregulation in MASLD.免疫失调在 MASLD 中的作用。
Biomed Pharmacother. 2024 Jan;170:116069. doi: 10.1016/j.biopha.2023.116069. Epub 2023 Dec 25.
10
IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.脂肪变性肝细胞和巨噬细胞中的 IL-17 信号转导促进酒精性肝病中的肝细胞癌。
J Hepatol. 2020 May;72(5):946-959. doi: 10.1016/j.jhep.2019.12.016. Epub 2019 Dec 31.

引用本文的文献

1
Sex steroid hormones drive dimorphic responses in GDF15-deficient mouse models of cardiometabolic diseases.性类固醇激素在心脏代谢疾病的GDF15缺陷小鼠模型中驱动二态反应。
Sci Rep. 2025 Aug 26;15(1):31326. doi: 10.1038/s41598-025-13662-4.
2
The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.细胞因子在代谢功能障碍相关脂肪性肝病中的有趣作用:一篇叙述性综述
Curr Obes Rep. 2025 Aug 12;14(1):65. doi: 10.1007/s13679-025-00657-5.
3
Characterization of inflammatory protein expression patterns and their association with viral DNA load in hepatitis B virus infection via Olink proteomics analysis.
通过Olink蛋白质组学分析对乙型肝炎病毒感染中炎症蛋白表达模式及其与病毒DNA载量的关联进行表征。
Am J Transl Res. 2025 Jun 15;17(6):4701-4712. doi: 10.62347/JTXH6594. eCollection 2025.
4
Growth differentiation factor-15 as a non-invasive biomarker of liver fibrosis in sickle cell disease.生长分化因子-15作为镰状细胞病肝纤维化的非侵入性生物标志物。
Int J Hematol. 2025 Jul 13. doi: 10.1007/s12185-025-04035-8.
5
Levels of Growth Differentiation Factor 15 Correlated with Metabolic Dysfunction-Associated Steatotic Liver Disease in Children.生长分化因子15水平与儿童代谢功能障碍相关脂肪性肝病的关系
Int J Mol Sci. 2025 Jul 5;26(13):6486. doi: 10.3390/ijms26136486.
6
Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells.肝脏内稳态与疾病中的炎症和免疫:肝细胞、非实质细胞与免疫细胞的关联
Cell Mol Immunol. 2025 Jul 1. doi: 10.1038/s41423-025-01313-7.
7
Relevance of GDF15 as a biomarker for clinical outcomes after bariatric surgery.生长分化因子15作为减肥手术后临床结局生物标志物的相关性。
J Endocrinol. 2025 Jul 1;266(1). doi: 10.1530/JOE-25-0010.
8
Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression.肝细胞中转化生长因子-β超家族细胞因子的双信号通路:平衡肝脏内稳态与疾病进展
Front Pharmacol. 2025 Apr 7;16:1580500. doi: 10.3389/fphar.2025.1580500. eCollection 2025.
9
Targeting senescent hepatocytes for treatment of metabolic dysfunction-associated steatotic liver disease and multi-organ dysfunction.靶向衰老肝细胞治疗代谢功能障碍相关脂肪性肝病和多器官功能障碍。
Nat Commun. 2025 Mar 28;16(1):3038. doi: 10.1038/s41467-025-57616-w.
10
GDF15 Circulating Levels Are Associated with Metabolic-Associated Liver Injury and Atherosclerotic Cardiovascular Disease.生长分化因子15循环水平与代谢相关肝损伤及动脉粥样硬化性心血管疾病相关。
Int J Mol Sci. 2025 Feb 26;26(5):2039. doi: 10.3390/ijms26052039.